Biomerica, Inc.
BMRA
$2.80
$0.041.45%
NASDAQ
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -32.89% | 10.03% | 4.40% | 5.49% | 0.72% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -32.89% | 10.03% | 4.40% | 5.49% | 0.72% |
| Cost of Revenue | -9.40% | -5.66% | -3.46% | 16.68% | 1.58% |
| Gross Profit | -1,320.00% | 112.75% | 34.46% | -29.85% | -31.03% |
| SG&A Expenses | -16.76% | -32.89% | -22.88% | 16.04% | -14.24% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -12.52% | -22.80% | -17.20% | 7.81% | -10.19% |
| Operating Income | -2.36% | 39.50% | 38.25% | -11.04% | 16.78% |
| Income Before Tax | -8.84% | 39.03% | 36.42% | -18.30% | 20.52% |
| Income Tax Expenses | -28.57% | -200.00% | -137.50% | -82.61% | -46.15% |
| Earnings from Continuing Operations | -8.66% | 39.36% | 36.96% | -16.25% | 20.70% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -8.66% | 39.36% | 36.96% | -16.25% | 20.70% |
| EBIT | -2.36% | 39.50% | 38.25% | -11.04% | 16.78% |
| EBITDA | -2.32% | 39.95% | 38.93% | -11.23% | 17.16% |
| EPS Basic | -3.61% | 46.84% | 38.06% | -16.25% | 21.84% |
| Normalized Basic EPS | -3.81% | 46.55% | 37.54% | -18.33% | 21.66% |
| EPS Diluted | -7.32% | 46.84% | 33.33% | -14.29% | 21.29% |
| Normalized Diluted EPS | -3.81% | 46.55% | 37.54% | -18.33% | 21.66% |
| Average Basic Shares Outstanding | 4.87% | 14.06% | 1.78% | 0.00% | 1.46% |
| Average Diluted Shares Outstanding | 4.87% | 14.06% | 1.78% | 0.00% | 1.46% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |